...
首页> 外文期刊>Cytokine >Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway
【24h】

Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway

机译:细胞色素P450 2J3 / 11,12-环氧二十碳三烯酸的上调通过caspase依赖性途径抑制新生大鼠心肌细胞的凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

Short, nonlethal ischemic episodes administered to hearts directly after ischemic events (ischemic postconditioning, IPost) have an advantage over ischemic preconditioning (IPC). The endogenous cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid (CYP2J3/11,12-EET) is upregulated by IPost, but not IPC, in the rat heart. The CYP epoxygenase inhibitor N-methylsulphonyl-6-(2-propargyloxyphenyl) hexanamide (MS-PPOH) reduces the cardioprotective effects of IPost, but not IPC. We proposed that upregulation of CYP2J3/11,12-EET during IPost induces cardioprotection by inhibiting cardiomyocyte apoptosis and that multiple apoptotic signals, including changes in mitochondrial membrane potential (MMP) and mitochondrial permeability transition pore (mPTP) opening, mitochondrial cytochrome c leakage, caspase-3 levels, and levels of protective kinases such as Bcl-2 and Bax, are involved in the process. Neonatal rat cardiomyocytes underwent 3-h hypoxia followed by 2-, 5-, or 6-h reoxygenation (H/R) or three cycles of 5-min reoxygenation followed by 5-min hypoxia before 90-min reoxygenation (HPost); or were transfected with pcDNA3.1-CYP2J3 for 48. h before H/R; or were treated with MS-PPOH for 10. min before HPost. For HPost alone, pcDNA3.1-CYP2J3 transfection attenuated cardiomyocyte apoptosis to 68.4% (p< 0.05) of that with H/R. pcDNA3.1-CYP2J3 transfection significantly decreased MMP and inhibited mPTP opening induced by H/R, reduced mitochondrial cytochrome c leakage, cleaved caspase-3 protein expression, and increased the ratio of Bcl-2 to Bax expression. MS-PPOH abolished this effect. Therefore, upregulation of CYP2J3/11,12-EET during HPost is involved in cardioprotection by inhibiting apoptosis via a caspase-dependent pathway, and the apoptosis-suppressive effect may have important clinical implications during HPost.
机译:缺血事件(缺血后处理,IPost)后直接施用于心脏的短暂,非致命性缺血发作优于缺血预处理(IPC)。内源性细胞色素P450 2J3 / 11,12-环氧二十碳三烯酸(CYP2J3 / 11,12-EET)在大鼠心脏中被IPost上调,但不被IPC上调。 CYP环氧合酶抑制剂N-甲基磺酰基-6-(2-炔丙基氧基苯基)己酰胺(MS-PPOH)会降低IPost的心脏保护作用,但不会降低IPC的心脏保护作用。我们提出IPost期间CYP2J3 / 11,12-EET的上调可通过抑制心肌细胞凋亡来诱导心脏保护作用,并提示多种凋亡信号,包括线粒体膜电位(MMP)和线粒体通透性过渡孔(mPTP)打开,线粒体细胞色素c泄漏,该过程涉及caspase-3水平以及保护性激酶(例如Bcl-2和Bax)的水平。新生大鼠心肌细胞进行3小时缺氧,然后进行2、5或6小时复氧(H / R)或三个周期的5分钟复氧,然后在90分钟复氧之前进行5分钟缺氧(HPost);在H / R之前,用pcDNA3.1-CYP2J3转染48小时。或在HPost之前用MS-PPOH处理10分钟。对于单独的HPost,pcDNA3.1-CYP2J3转染将心肌细胞的凋亡减至H / R的68.4%(p <0.05)。 pcDNA3.1-CYP2J3转染可显着降低H / R诱导的MMP并抑制mPTP开放,减少线粒体细胞色素c泄漏,切割caspase-3蛋白表达并增加Bcl-2与Bax表达的比率。 MS-PPOH取消了这种效果。因此,HPost期间CYP2J3 / 11,12-EET的上调通过半胱天冬酶依赖性途径抑制细胞凋亡,从而参与了心脏保护作用,而细胞凋亡抑制作用可能在HPost过程中具有重要的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号